Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | APP | P05067 | 2/20 | 0.42 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.42 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488274 | 0.85 | TDP1 (0.49) | TDP1APPSLC5A1SLC5A2XDH | |
| SCHEMBL23488550 | 0.84 | MAOB (0.43) | TDP1SLC5A1SLC5A2XDHLGALS8 | |
| SCHEMBL23488464 | 0.84 | MAOB (0.43) | TDP1SLC5A1SLC5A2XDHLGALS8 | |
| SCHEMBL23488306 | 0.84 | TDP1 (0.41) | TDP1APPSLC5A1SLC5A2XDH | |
| SCHEMBL23488297 | 0.83 | TDP1 (0.48) | TDP1SLC5A1SLC5A2XDHLGALS8 | |
| SCHEMBL23488472 | 0.82 | MAOB (0.43) | TDP1SLC5A1SLC5A2LGALS8TYMP | |
| SCHEMBL23488662 | 0.82 | LGALS8 (0.47) | APPSLC5A1SLC5A2LGALS8PDCD1 | |
| SCHEMBL23488661 | 0.82 | LGALS8 (0.56) | APPSLC5A1LGALS8PDCD1CD274 | |
| SCHEMBL23488668 | 0.81 | CHRNB2 (0.51) | TDP1SLC5A1SLC5A2XDHLGALS8 | |
| SCHEMBL23488128 | 0.81 | CHRNB2 (0.51) | TDP1SLC5A1SLC5A2XDHLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TDP1 4093/4885APP 3466/4885SLC5A1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.